Quotes 5-day view End-of-day quote Shanghai Stock Exchange
09/14/2020
09/15/2020
09/16/2020
09/17/2020
09/18/2020
Date
91.36
91.1
89.74
86.29
88.98
Last
15482410
14888130
19517120
42304510
29771720
Volume
-0.49% -0.28% -1.49% -3.84% +3.12% Change
Sales 2020
29 140 M 4 311 M 4 311 M
Net income 2020
6 616 M 979 M 979 M
Net cash position 2020
13 807 M 2 043 M 2 043 M
P/E ratio 2020
68,0x
Yield 2020
0,24%
Sales 2021
36 692 M 5 428 M 5 428 M
Net income 2021
8 544 M 1 264 M 1 264 M
Net cash position 2021
18 477 M 2 734 M 2 734 M
P/E ratio 2021
52,4x
Yield 2021
0,31%
Capitalization
456 B 67 413 M 67 457 M
EV / Sales 2020
15,2x
EV / Sales 2021
11,9x
Nbr of Employees
24 431
Free-Float
44,6%
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Notations Surperformance© of Jiangsu Hengrui Medicine Co., Ltd.
Trading Rating : Investor Rating :
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
News in other languages on JIANGSU HENGRUI MEDICINE CO., LTD.
Chart JIANGSU HENGRUI MEDICINE CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends JIANGSU HENGRUI MEDICINE CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
25
Average target price
100,49 CNY
Last Close Price
86,29 CNY
Spread / Highest target
38,4%
Spread / Average Target
16,5%
Spread / Lowest Target
-13,6%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
